The Asia Pacific Citrus Concentrate Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Vacuum concentration calls for heating fruit juice under low pressure to lower the boiling point and hasten the evaporation of the water content. Vacuum concentration equipment is the most significant and often used machinery in producing fruit juice concentrate. It may be divided into focus devices with a single effect and numerous effects. It comprises centrifugal film evaporators, rising film evaporators, falling film evaporators, plate-type evaporators, scraper evaporators, and central circulation tube evaporators based on the heater structure. As for heat pump concentration systems, they employ inflated refrigerants as a cooling agent and the heat produced by refrigerators as a heat source, resulting in increased heat usage.
The concentration temperature is dropped to 15-20e under high vacuum conditions, which may preserve the concentrated juice's quality. Primary steam and secondary steam provide the heat needed for evaporation and concentration. The former process is called single-effect evaporation, in which secondary steam is immediately condensed rather than heated. Multiple-effect evaporation is used when secondary steam is employed for yet another heating. Fruit juice concentrate typically undergoes 1–5 times of evaporation, increasing the solid content from 5%–15% to 70%–72%.
Japan is one of the largest pharmaceutical industries in the world. Since 2013, the Government of Japan has promoted the healthcare industry as a major development engine for the country's economic restoration and expansion agenda. The pharmaceutical and healthcare industries in Japan have recently attracted fresh interest. This increased interest in Japan's healthcare industry is partly due to the COVID-19 pandemic, highlighting the value of new healthcare goods. Strengthening Japan's drug development environment is a significant additional element driving interest in the country's pharmaceutical industry. The pharmaceuticals industry's growth and the rising consumer demand for organic-based products are anticipated to surge the adoption of citrus concentrate in the pharma industry and drive market growth in the region.
The China market dominated the Asia Pacific Citrus Concentrate Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $949.1 million by 2028. The Japan market is estimated to grow a CAGR of 4.9% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.2% during (2022 - 2028).
Based on Nature, the market is segmented into Conventional, and Organic. Based on Source, the market is segmented into Oranges, Tangerines, Lemon & Limes, Grapefruits, and Others. Based on Form, the market is segmented into Liquid, and Dry. Based on Sales Channel, the market is segmented into B2B, and B2C. Based on End-use, the market is segmented into Food & Beverages, Pharmaceuticals, Nutraceuticals, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Citrus Concentrate Market is Projected to reach USD 10.8 Billion by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Döhler Gmbh, IPRONA SPA, Louis Dreyfus Company B.V., SunOpta, Inc, Kiril Mischeff Limited, Vinayak Ingredients (INDIA) Pvt. Ltd., Asia Farm F&B Pte Ltd, Citrus Systems, Inc., Prodalim B.V., and El-Marwa Food Industries Co.
By Nature
By Source
By Form
By Sales Channel
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
